[APLS] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -36.72%
YoY- -36.17%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 12 0 0 0 0 0 0 -
PBT -18,256 -11,573 -12,126 -9,051 -6,620 -7,211 -6,647 95.75%
Tax -17,896 -11,589 -12,138 -9,063 -6,679 -7,234 38 -
NP -18,256 -11,573 -12,126 -9,051 -6,620 -7,211 -6,647 95.75%
Tax Rate - - - - - - - -
Total Cost 18,267 11,573 12,126 9,051 6,620 7,211 6,647 95.83%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -158,169.26 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.36 -0.30 -0.67 -0.50 -0.37 -0.40 -0.79 -40.69%
EPS Diluted -0.36 -0.30 -0.67 -0.50 -0.37 -0.40 -0.79 -40.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.